MISAGO 2: One-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients

Journal of Endovascular Therapy

Volumn 19, Issue 6, 2012, Pages 774-784

  Schulte, Karl Ludwig ^a   Kralj, Ivan ^b   Gissler, Hans Martin ^c   Bagnaschino, Luis Alberto ^d   Buschmann, Ivo ^a   Pernès, Jean Marc ^e   Haage, Patrick ^f   Goverde, Peter ^g   Beregi, Jean Paul ^h   Válka, Martin ⁱ   Boudny, Jaroslav ^j   Geibel, Thomas ^k   Velkoborsky, Marek ^l   Zähringer, Markus ^m   Paetzel, Christian ⁿ   Fanelli, Fabrizio ^o   Müller Hülsbeck, Stefan ^k   Zeller, Thomas ^k   Langhoff, Ralf ^a  

^a Königin Elisabeth Herzberge Hospital   (Germany)

^b Diakonissen Krankenhaus Rüppurr   (Germany)

^c Hochrhein Eggberg Klinik   (Germany)

^d HOSPITAL DE TORREVIEJA   (Spain)

^e Hôpital Privé d'Antony   (France)

^f HELIOS KLINIKUM WUPPERTAL   (Germany)

^g Stuivenberg General Hospital   (Belgium)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ Vitkovice vyzkum a vyvoj technicke aplikace as   (Czech Republic)

^j UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^k Praxisklinik Minden ^*  (Germany)

^l Nový Ji ín Hospital and Polyclinic   (Czech Republic)

^m MARIENHOSPITAL STUTTGART   (Germany)

ⁿ Klinikum Weiden   (Germany)

^o SAPIENZA UNIVERSITY OF ROME   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NITINOL; TICLOPIDINE;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY OCCLUSION; ARTICLE; CLAUDICATION; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; EVENT FREE SURVIVAL; FEMALE; FEMOROPOPLITEAL BYPASS; HUMAN; ISCHEMIA; LEG REVASCULARIZATION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MISAGO SELF EXPANDING RAPID EXCHANGE NITINOL STENT; MULTICENTER STUDY; OBSERVATIONAL STUDY; PATIENT SAFETY; POPLITEAL ARTERY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS FAILURE; RECURRENT DISEASE; SELF EXPANDING STENT; SUPERFICIAL FEMORAL ARTERY;

AGED; ALLOYS; ARTERIAL OCCLUSIVE DISEASES; CHI-SQUARE DISTRIBUTION; CHILE; CONSTRICTION, PATHOLOGIC; DISEASE-FREE SURVIVAL; ENDOVASCULAR PROCEDURES; EUROPE; FEMALE; FEMORAL ARTERY; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; ISRAEL; LIFE TABLES; MALE; MIDDLE AGED; POPLITEAL ARTERY; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RECURRENCE; REGISTRIES; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84871286726     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/JEVT-12-3861MR.1     Document Type: Article

References (25)

1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75.
2. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
3. Zeller T, Tiefenbacher C, Steinkamp HJ, et al. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT). J Endovasc Ther. 2008;15:390-398.
4. Scheinert D, Grummt L, Piorkowski M, et al. A novel self-expanding interwoven nitinol stent for complex femoropopliteal lesions: 24-month results of the SUPERA SFA registry. J Endovasc Ther. 2011;18:745-752.
5. Iida O, Soga Y, Hirano K, et al. Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis. J Endovasc Ther . 2011;18:753-761.
6. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther. 2012;19:1-9.
7. Schillinger M, Sabeti S, Loewe C et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888. (Pubitemid 43872689)
8. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006;47:1239-1312.
9. Rooke TW, Hirsch AT, Misra S, et al.; American College of Cardiology Foundation; American Heart Association; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society for Vascular Medicine; Society for Vascular Surgery. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. Catheter Cardiovasc Interv. 2012;79:501-531.
10. European Stroke Organisation. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2851-2906.
11. Kasapis C, Henke PK, Chetcuti SJ, et al. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J. 2009;30:44-55.
12. Jahnke T, Schäfer JP, Bolte H, et al. Retrospective study of rapid-exchange monorail versus over-the-wire technique for femoropopliteal angioplasty. Cardiovasc Intervent Radiol. 2008;31:854-859.
13. Schulte KL, Müller-Hülsbeck S, Cao P, et al. MISAGO 1: first-in-man clinical trial with Misago nitinol stent. EuroIntervention. 2010;5:687-691.
14. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517-538. (Pubitemid 27408567)
15. Krankenberg H, Schlüter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the Femoral Artery Stenting Trial (FAST). Circulation. 2007;116:285-292. (Pubitemid 47196564)
16. Duda S, Scheinert D, Zeller T, et al. Twelve-month results of a randomized multi-center head-to-head comparison of the S.M.A.R.T. CONTROL nitinol Stent (Cordis) with the Luminexx 6F Stent (Bard) for the treatment of long TASC C and D superficial femoral artery lesions: the SUPER-SL study. Abstract presented at CIRSE 2008; September 13-17, 2008; Copenhagen, Denmark.
17. Laird JR, Katzen BT, Scheinert D, et al.; for the RESILIENT Investigators. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv. 2010;3:267-276.
18. Bosiers M, Torsello G, Gissler HM, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther. 2009;16:261-269.
19. Tessarek J. Update on 24 months single arm Zilver PTX results and overview of 12 months randomized trial results. Abstract presented at LINC 2011; January 19, 2011; Leipzig, Germany.
20. Wolf GL, Wilson SE, Cross AP, et al. Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199. J Vasc Interv Radiol. 1993;4:639-648.
21. Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925-1934. (Pubitemid 41713982)
22. Bradbury AW, Adam DJ, Bell J, et al.; for the BASIL trial Participants. Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010;51(5 Suppl):5S-17S.
23. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312-315. (Pubitemid 40094743)
24. Schlager O, Dick P, Sabeti S, et al. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther. 2005;12:676-684. (Pubitemid 43100925)
25. Keo HH, Kickuth R, Diehm N, Baumgartner I, Dai-Do D. Incidence and clinical implications of stent fractures of the Xpert self-expanding nitinol stent in infrainguinal arteries. Vasa. 2009;38:47-52.